Anti-tumor activity of elacestrant (RAD1901) in combination with alpelisib (BYL-719) in patient-derived xenograft models of ER plus breast cancer

被引：0
|
作者：
Sankaran, Banu
Garner, Fiona
Hattersley, Gary
Purandare, Dinesh
Bihani, Teeru
机构：
[1] Novartis, Cambridge, MA USA
[2] Radius Hlth, Waltham, MA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-04-14
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Anti-tumor activity of tepotinib in orthotopic models of lung cancer patient-derived brain metastases with MET amplification
    Friese-Hamim, Manja
    Clark, Anderson
    Crowley, Lindsey
    Reusch, Christof
    Bogatyrova, Olga
    Wilm, Claudia
    Zhang, Hong
    Crandall, Timothy
    Lin, Jing
    Ma, Jianguo
    Bachner, David
    Schmidt, Jurgen
    Schaefer, Martin
    Stroh, Christopher
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
    Guo, Zhanfang
    Luo, Jingqin
    Mashl, R. Jay
    Hoog, Jeremy
    Maiti, Piyush
    Fettig, Nikki
    Davies, Sherri R.
    Aft, Rebecca
    Held, Jason M.
    Govindan, Ramaswamy
    Ding, Li
    Li, Shunqiang
    von Morze, Cornelius
    Wulf, Gerburg M.
    Shoghi, Kooresh I.
    Ma, Cynthia X.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (06): : 1430 - 1440
  • [23] Correlation between TNFα and LCL161 anti-tumor activity in patient derived xenograft models of human cancer
    Firestone, Brant
    Conway, Colleen
    Yang, Guizhi
    Gao, Hui
    Porter, Dale
    Slisz, Joanna
    He, Dan
    Mosher, Rebecca
    Monahan, John
    Straub, Christopher
    Morrissey, Michael
    Yao, Yung-mae
    Zawel, Leigh
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [24] Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models
    Sprouffske, Kathleen
    Kerr, Grainne
    Li, Cheng
    Prahallad, Anirudh
    Rebmann, Ramona
    Waehle, Verena
    Naumann, Ulrike
    Bitter, Hans
    Jensen, Michael R.
    Hofmann, Francesco
    Brachmann, Saskia M.
    Ferretti, Stephane
    Kauffmann, Audrey
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 323 - 331
  • [25] Developing patient-derived xenograft tumor models that recapture clinical manifestation of inflammatory breast cancer patients
    Qiang, Wenan
    Zhang, Youbin
    Gursel, Demirkan Gursel
    Wei, Jian-Jun
    James, Charles David
    O'Halloran, Thomas V.
    Cristofanilli, Massimo
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Anti-tumor activity of a liposomal formulation of Eribulin compared with the same dose of Eribulin in patient-derived breast cancer xenografts
    Tanioka, Maki
    Semba, Taro
    Shimoi, Tatsunori
    Niwa, Yuki
    Yonemori, Kan
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Preclinical Anti-Tumor Activity of Hexabody-CD38 in Patient-Derived B Cell Lymphoma and Acute Myeloid Leukemia Xenograft Models
    Hiemstra, Ida H.
    Janmaat, Maarten L.
    Boross, Peter
    Van den Brakel, Jeroen
    ten Hagen, Wessel
    van Dooremalen, Sanne
    Bosgra, Sieto
    De Goeij, Bart E. C. G.
    Andringa, Grietje
    Kil, Laurens
    Sasser, A. Kate
    Ahmadi, Tahamtan
    Satijn, David
    Breij, Esther C. W.
    BLOOD, 2020, 136
  • [28] Antitumor Activity of Eribulin After Fulvestrant Plus CDK4/6 Inhibitor in Breast Cancer Patient-derived Xenograft Models
    Niwa, Yuki
    Asano, Makoto
    Nakagawa, Takayuki
    France, Damien
    Semba, Taro
    Funahashi, Yasuhiro
    ANTICANCER RESEARCH, 2020, 40 (12) : 6699 - 6712
  • [29] Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations
    Pico, Christian X. Cruz
    Li, Dali
    Lanier, Christopher D.
    Evans, Kurt
    Raso, Maria G.
    DiPeri, Timothy
    Rizvi, Yasmeen
    Ha, Min Jin
    Chen, Huiqin
    Zhao, Ming
    Akcakanat, Argun
    Zheng, Xiaofeng
    Toruner, Gokce
    Yuca, Erkan
    Scott, Stephen
    Wengner, Antje M.
    Yap, Timothy A.
    Meric-Bernstam, Funda
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [30] Synergistic anti-cancer activity of palbociclib in combination with sunitinib in patient-derived xenograft (PDX) models of various human cancers types
    Moskovits, Neta
    Peretz, Idit
    Chausky, Eva
    Meerson, Raisa
    Itzhaki, Ella
    Marsiano, Noga
    Shmuel, Nofar
    Yaffe, Ranny
    Edison, Natalia
    Goldman, Tal
    Stemmer, Salomon
    CANCER RESEARCH, 2020, 80 (16)
12345